ESC 365 - Moderate mixed aortic valve disease -evaluation, treatment and prognosis of patients referred to heart valve center

ESC Professional Premium Access

Moderate mixed aortic valve disease -evaluation, treatment and prognosis of patients referred to heart valve center

Session: The taunt of moderate mixed/multiple valvular disease

Topic: Aortic Valve Disease, Other

Speaker: Doctor P. Lupinek (Prague, CZ)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Petr Lupinek

Institute for Clinical and Experimental Medicine (IKEM), Prague (Czechia)

0 follower

4 more presentations in this session

Predictors of long-term outcomes of patients with concomitant moderate aortic and mitral valves diseases: a single tertiary care center experience 2010-2018

Speaker: Doctor M. Desai (Cleveland, US)

Survival and predictors of outcome in moderate mixed aortic valve disease

Speaker: Doctor K. Patel (London, GB)

Aortic stenosis drives the differential in survival in patients with concomitant moderate aortic and mitral valves diseases

Speaker: Doctor M. Desai (Cleveland, US)

The impact of calcium and vitamin D supplement intake on survival in patients with concomitant moderate aortic and mitral valve disease

Speaker: Doctor M. Desai (Cleveland, US)

Access the full session

The taunt of moderate mixed/multiple valvular disease

Speakers: Doctor P. Lupinek, Doctor M. Desai, Doctor K. Patel, Doctor M. Desai, Doctor M. Desai

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources